Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Evaxion Biotech A/S

    NASDAQ: EVAX · Real-Time Price · USD
    2.11
    -0.29 (-12.08%)
    At close: Jun 17, 2025, 3:59 PM
    2.05
    -2.74%
    Pre-market: Jun 18, 2025, 04:27 AM EDT

    Evaxion Biotech A/S Statistics

    Share Statistics

    Evaxion Biotech A/S has 1.4M shares outstanding. The number of shares has increased by 0.02% in one year.

    Shares Outstanding

    n/a
    		 1.4M

    Shares Change (YoY)

    n/a
    		 0.02%

    Shares Change (QoQ)

    n/a
    		 -0.48%

    Owned by Institutions (%)

    n/a
    		 15.81%

    Shares Floating

    n/a
    		 1.13M

    Failed to Deliver (FTD) Shares

    n/a
    		 455

    FTD / Avg. Volume

    n/a
    		 0.49%

    Short Selling Information

    The latest short interest is 71K, so 1.12% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 71K

    Short % of Shares Out

    n/a
    		 1.12%

    Short % of Float

    n/a
    		 1.5%

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is -0.43 and the forward PE ratio is -1.96. Evaxion Biotech A/S's PEG ratio is 0.01.

    PE Ratio

    n/a
    		 -0.43

    Forward PE

    n/a
    		 -1.96

    PS Ratio

    n/a
    		 1.36

    Forward PS

    n/a
    		 0

    PB Ratio

    n/a
    		 -2.75

    P/FCF Ratio

    n/a
    		 -0.35

    PEG Ratio

    n/a
    		 0.01
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Evaxion Biotech A/S.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 2.01, with a Debt / Equity ratio of -6.11.

    Current Ratio

    n/a
    		 2.01

    Quick Ratio

    n/a
    		 2.01

    Debt / Equity

    n/a
    		 -6.11

    Debt / EBITDA

    n/a
    		 -1.03

    Debt / FCF

    n/a
    		 -0.78

    Interest Coverage

    n/a
    		 -15.31

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $72,695.65

    Profits Per Employee

    n/a
    		 $-229,717.39

    Employee Count

    n/a
    		 46

    Asset Turnover

    n/a
    		 0.27

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 -788K

    Effective Tax Rate

    n/a
    		 6.94%

    Stock Price Statistics

    The stock price has increased by -84.19% in the last 52 weeks. The beta is 0.1, so Evaxion Biotech A/S's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.1

    52-Week Price Change

    n/a
    		 -84.19%

    50-Day Moving Average

    n/a
    		 1.89

    200-Day Moving Average

    n/a
    		 6.2

    Relative Strength Index (RSI)

    n/a
    		 43.24

    Average Volume (20 Days)

    n/a
    		 92,250

    Income Statement

    In the last 12 months, Evaxion Biotech A/S had revenue of 3.34M and earned -10.57M in profits. Earnings per share was -10.

    Revenue

    n/a
    		 3.34M

    Gross Profit

    n/a
    		 3.34M

    Operating Income

    n/a
    		 -14.73M

    Net Income

    n/a
    		 -10.57M

    EBITDA

    n/a
    		 -9.77M

    EBIT

    n/a
    		 -10.39M

    Earnings Per Share (EPS)

    n/a
    		 -10
    Full Income Statement

    Balance Sheet

    The company has 5.05M in cash and 10.1M in debt, giving a net cash position of -5.05M.

    Cash & Cash Equivalents

    n/a
    		 5.05M

    Total Debt

    n/a
    		 10.1M

    Net Cash

    n/a
    		 -5.05M

    Retained Earnings

    n/a
    		 -118.54M

    Total Assets

    n/a
    		 12.48M

    Working Capital

    n/a
    		 4.4M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -12.94M and capital expenditures 0, giving a free cash flow of -12.94M.

    Operating Cash Flow

    n/a
    		 -12.94M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -12.94M

    FCF Per Share

    n/a
    		 -0.6
    Full Cash Flow Statement

    Margins

    Gross margin is 100%, with operating and profit margins of -440.55% and -316%.

    Gross Margin

    n/a
    		 100%

    Operating Margin

    n/a
    		 -440.55%

    Pretax Margin

    n/a
    		 -339.56%

    Profit Margin

    n/a
    		 -316%

    EBITDA Margin

    n/a
    		 -292.14%

    EBIT Margin

    n/a
    		 -440.55%

    FCF Margin

    n/a
    		 -386.96%

    Dividends & Yields

    EVAX does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for EVAX is $10, which is 373.9% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $10

    Price Target Difference

    n/a
    		 373.9%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 2
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Jan 14, 2025. It was a backward split with a ratio of 1:5.

    Last Split Date

    n/a
    		 Jan 14, 2025

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:5

    Scores

    Altman Z-Score

    n/a
    		 -15.3

    Piotroski F-Score

    n/a
    		 4

    Add to Watchlist